The Advisory Committee on Immunization Practices (ACIP) recommends a preference for the nasal spray flu vaccine (LAIV) over the flu shot (IIV) for healthy children aged 2-8 when available. This decision aims to enhance vaccination strategies for pediatric populations.
Today, the Advisory Committee on Immunization Practices (ACIP) voted to recommend a preference for using the nasal spray flu vaccine (i.e., LAIV) instead of the flu shot (i.e., IIV) in healthy children 2-8 years of age when it is immediately available. ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC).
Original title: “Advisory Committee on Immunization Practices (ACIP) recommends a preference for using the nasal spray flu vaccine - Media Statement”